#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immune-mediated myasthenia gravis Lupus nephritis Thrombotic thrombocytopenic purpura Hodgkin's disease Progressive supranuclear palsy Cystic fibrosis respiratory infection suppression Hypoparathyroidism Primary amyloidosis Hereditary neuropathic amyloidosis Cutaneous T-cell lymphoma refractory Angiosarcoma non-metastatic Anaplastic thyroid cancer Endometrial adenocarcinoma Glomerulonephritis membranoproliferative Ovarian epithelial cancer More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic Soft tissue sarcoma Haemophilia A with anti factor VIII – Basic Information Mitochondrial myopathy – Treatment Breast angiosarcoma – Diagnostics Synovial sarcoma – Diagnostics Retinoblastoma Retinitis pigmentosa – Basic Information Gastrointestinal stromal tumour – Trials in Disease Glomerulonephritis rapidly progressive – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Glpg3667 Fumarate Fludarabine Phosphate Ph. Eur. Palopegteriparatide Tirzepatide Desonide THEOPHYLLINE ANHYDROUS Bcmacp03 Heterodimeric Interleukin-15 Denosumab Magnesium Hydroxide Nitrous Oxide Clindamycin Thiamine Nitrate Bp Mk-4830 Bio89-100 F44/10 Febuxostat Fadraciclib Amivantamab Gallium (68Ga) More therapies…

    Learn about Your Condition

    Primary hypercholesterolaemia Papulopustular rosacea Metastases to liver H1N1 influenza Brain cancer metastatic Large cell lung cancer stage 0 Arteriovenous graft thrombosis Eye disorder Deafness traumatic Hypertrophic cardiomyopathy Kawasaki's disease Craniopharyngioma Adenocarcinoma Acarodermatitis Retroperitoneal fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Laiko General Hospital Of Athens

Laiko General Hospital Of Athens

Messogion Avenue 152, Athens, 115 27, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Avibactam and Drug Combination for Treating Severe Infections in Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Anidulafungin
    • Avibactam
    • Ceftazidime
    Greece

  • Study on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Drugs:
    • Deucravacitinib
    Bulgaria Czechia Greece Hungary Poland Portugal +1

  • Study on the Effects of Atacicept in Adults with IgA Nephropathy

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Atacicept
    • Enalapril
    • Losartan
    Belgium Croatia Czechia Denmark Estonia France +7

  • Study on the Effects of S-217622 for Adults Hospitalized with COVID-19

    Not recruiting

    3 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • (6E)-6-[(6-Chloro-2-Methyl-2H-Indazol-5-Yl)Imino]-3-[(1-Methyl-1H-1,2,4-Triazol-3-Yl)Methyl]-1-[(2,4,5-Trifluorophenyl)Methyl]-1,3,5-Triazinane-2,4-Dione
    Denmark Germany Greece Ireland Poland Spain

  • Study on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Axial spondyloarthritis
    Investigated Drugs:
    • Filgotinib
    Belgium Bulgaria Croatia Czechia Estonia France +9

  • Study on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Glucose Monohydrate
    • Sodium Chloride
    • Topotecan
    Austria Belgium Bulgaria Germany Greece Hungary +2

  • Study on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Factor IX deficiency
    Investigated Drugs:
    • Fidanacogene Elaparvovec
    Belgium France Germany Greece Italy Spain +1

  • Study on Fitusiran for Preventing Bleeding in Males Aged 12 and Older with Severe Hemophilia A or B, with or without Inhibitors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Haemophilia
    Investigated Drugs:
    • Damoctocog Alfa Pegol
    • Factor Viii Inhibitor Bypassing Fraction
    • Fitusiran
    France Germany Greece Italy Poland Spain

  • Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

    Not recruiting

    3 1
    Investigated Drugs:
    • Citicoline Sodium
    Belgium France Greece Hungary Italy Poland +1
Previous Page
1 … 34 35 36 37 38
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!